Fig. 3From: miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancerMiR-1296-5p is down-regulated in ERBB2-positive breast cancer tissues. The miR-1296-5p expression is suppressed in a majority of ERBB2-positive breast cancer samples (n = 40) when compared to ERBB2-negative breast cancer samples (n = 74). The miRNA relative expression levels were normalized to the average value of ERBB2-positive breast cancer samplesBack to article page